MYC is dysregulated in more than 50% of cancers of all tissues but is especially implicated in prostate cancers and B-cell cancers such as Burkitt’s lymphoma, which is driven by chromosomal translocation of MYC (7, 8, 9). This evidence concerns the gene MYC and prostate carcinoma.